| Primary |
| Hypertension |
56.7% |
| Product Used For Unknown Indication |
10.0% |
| Mineral Supplementation |
6.7% |
| Blood Pressure |
4.2% |
| Blood Pressure Increased |
3.3% |
| Peripheral Arterial Occlusive Disease |
3.3% |
| Asthma |
1.7% |
| Colitis Ulcerative |
1.7% |
| Diabetes Mellitus |
1.7% |
| Dyslipidaemia |
1.7% |
| Thyroid Disorder |
1.7% |
| Angina Pectoris |
0.8% |
| Blood Glucose Abnormal |
0.8% |
| Blood Pressure Abnormal |
0.8% |
| Essential Hypertension |
0.8% |
| Glomerulonephritis Membranous |
0.8% |
| Hepatic Encephalopathy |
0.8% |
| Neuralgia |
0.8% |
| Portal Hypertension |
0.8% |
| Prophylaxis |
0.8% |
|
| Product Substitution Issue |
19.2% |
| Headache |
9.6% |
| Drug Ineffective |
7.7% |
| Blood Pressure Increased |
5.8% |
| Hyperhidrosis |
5.8% |
| Joint Swelling |
5.8% |
| Blood Pressure Inadequately Controlled |
3.8% |
| Hyperkalaemia |
3.8% |
| Loss Of Consciousness |
3.8% |
| Medication Residue |
3.8% |
| Oedema Peripheral |
3.8% |
| Palpitations |
3.8% |
| Product Quality Issue |
3.8% |
| Product Taste Abnormal |
3.8% |
| Tinnitus |
3.8% |
| Tongue Disorder |
3.8% |
| Alopecia |
1.9% |
| Angioedema |
1.9% |
| Angle Closure Glaucoma |
1.9% |
| Asthenia |
1.9% |
|
| Secondary |
| Hypertension |
42.9% |
| Product Used For Unknown Indication |
11.6% |
| Pain |
10.0% |
| Atrial Fibrillation |
3.6% |
| Drug Use For Unknown Indication |
3.6% |
| Cardiovascular Event Prophylaxis |
2.5% |
| Hyperlipidaemia |
2.5% |
| Type 2 Diabetes Mellitus |
2.5% |
| Constipation |
2.2% |
| Mineral Supplementation |
2.2% |
| Coronary Artery Disease |
1.9% |
| Essential Hypertension |
1.9% |
| Asthma |
1.7% |
| Diabetes Mellitus |
1.7% |
| Glaucoma |
1.7% |
| Polyuria |
1.7% |
| Prostate Cancer |
1.7% |
| Angina Pectoris |
1.4% |
| Ill-defined Disorder |
1.4% |
| Nausea |
1.4% |
|
| Renal Failure Acute |
11.7% |
| Aortic Dissection |
10.0% |
| Tremor |
8.3% |
| Hyponatraemia |
6.7% |
| Loss Of Consciousness |
6.7% |
| Myalgia |
6.7% |
| Faecaloma |
5.0% |
| Thrombocytopenia |
5.0% |
| Blood Potassium Increased |
3.3% |
| Blood Pressure Decreased |
3.3% |
| Bradycardia |
3.3% |
| Burnout Syndrome |
3.3% |
| Cough |
3.3% |
| Dizziness |
3.3% |
| Hyperkalaemia |
3.3% |
| Interstitial Lung Disease |
3.3% |
| Left Ventricular Dysfunction |
3.3% |
| Muscle Spasms |
3.3% |
| Oedematous Pancreatitis |
3.3% |
| Osmotic Demyelination Syndrome |
3.3% |
|
| Concomitant |
| Hypertension |
27.1% |
| Product Used For Unknown Indication |
24.3% |
| Drug Use For Unknown Indication |
7.3% |
| Rheumatoid Arthritis |
6.0% |
| Diabetes Mellitus |
5.2% |
| Type 2 Diabetes Mellitus |
3.0% |
| Atrial Fibrillation |
3.0% |
| Pain |
3.0% |
| Hepatitis C |
2.9% |
| Prophylaxis |
2.7% |
| Depression |
2.5% |
| Osteoporosis |
2.2% |
| Metastatic Renal Cell Carcinoma |
1.7% |
| Blood Cholesterol Increased |
1.4% |
| Blood Pressure |
1.4% |
| Dyslipidaemia |
1.4% |
| Hyperlipidaemia |
1.3% |
| Colorectal Cancer |
1.2% |
| Anxiety |
1.2% |
| Insomnia |
1.2% |
|
| Oedema Peripheral |
7.0% |
| Vomiting |
7.0% |
| Renal Failure Acute |
6.5% |
| Drug Ineffective |
5.9% |
| Nausea |
5.9% |
| Pneumonia |
5.9% |
| Pyrexia |
5.9% |
| Bronchiectasis |
5.4% |
| Diarrhoea |
4.9% |
| Headache |
4.9% |
| Weight Increased |
4.9% |
| Blood Pressure Increased |
4.3% |
| Renal Impairment |
4.3% |
| Rhabdomyolysis |
4.3% |
| Atrial Fibrillation |
3.8% |
| Dyspnoea |
3.8% |
| Pancytopenia |
3.8% |
| Rash |
3.8% |
| Renal Failure |
3.8% |
| Somnolence |
3.8% |
|
| Interacting |
| Pain |
26.1% |
| Hypertension |
17.4% |
| Ascites |
8.7% |
| Atrial Fibrillation |
8.7% |
| Hyperlipidaemia |
6.5% |
| Essential Hypertension |
4.3% |
| Varices Oesophageal |
4.3% |
| Anxiety |
2.2% |
| Arrhythmia |
2.2% |
| Benign Prostatic Hyperplasia |
2.2% |
| Coronary Artery Disease |
2.2% |
| Epilepsy |
2.2% |
| Mental Impairment |
2.2% |
| Myocardial Ischaemia |
2.2% |
| Nausea |
2.2% |
| Prophylaxis |
2.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.2% |
| Type 2 Diabetes Mellitus |
2.2% |
|
| Faecaloma |
30.0% |
| Drug Interaction |
20.0% |
| Hepatic Encephalopathy |
20.0% |
| Personality Change |
10.0% |
| Somnolence |
10.0% |
| Tremor |
10.0% |
|
